(COMTEX) B: La Jolla Diagnostics Announces Ongoing Discussions Regard
B: La Jolla Diagnostics Announces Ongoing Discussions Regarding DiagnosTech
Subsidiary
LA JOLLA, Calif., Feb 18, 2000 (BW HealthWire) -- La Jolla Diagnostics
Inc., (OTCBB:LAJD) announced today that it has entered ongoing
discussions regarding its subsidiary, DiagnosTech Inc.
Several companies have indicated an interest in the DiagnosTech, Inc.
line of rapid diagnostic tests, especially the company's rapid test for
active tuberculosis. Under discussion is the possibility of a strategic
joint venture, license, merger or outright acquisition of DiagnosTech
Inc.
The company cannot say what, if any, actions will be forthcoming as a
result of these discussions. La Jolla Diagnostics is an emerging
company engaged in the development and marketing of health care
products, dietary supplements, and through its subsidiary DiagnosTech
Inc., state-of-the-art rapid diagnostic tests including a unique
proprietary test for active tuberculosis.
Copyright (C) 2000 Business Wire. All rights reserved.
Distributed via COMTEX.
-0-
CONTACT: La Jolla Diagnostics Inc.
Don Brucker, 800/454-6790, Fax 619/454-7851
lajd.com
lajd96@aol.com
WEB PAGE: businesswire.com
GEOGRAPHY: CALIFORNIA
INDUSTRY CODE: MEDICAL
BIOTECHNOLOGY
PHARMACEUTICAL
MEDICAL
DEVICES
Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.
*** end of story *** |
